nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—CYP2C8—Vismodegib—skin cancer	0.19	0.319	CbGbCtD
Spironolactone—ABCB1—Vismodegib—skin cancer	0.128	0.216	CbGbCtD
Spironolactone—ABCC2—Docetaxel—skin cancer	0.107	0.18	CbGbCtD
Spironolactone—ABCB1—Dactinomycin—skin cancer	0.0675	0.113	CbGbCtD
Spironolactone—CYP2C8—Fluorouracil—skin cancer	0.0674	0.113	CbGbCtD
Spironolactone—ABCB1—Docetaxel—skin cancer	0.0348	0.0586	CbGbCtD
Spironolactone—AR—scrotum—skin cancer	0.0247	0.182	CbGeAlD
Spironolactone—Carcinoma breast—Docetaxel—skin cancer	0.0129	0.0497	CcSEcCtD
Spironolactone—SHBG—hindlimb—skin cancer	0.0117	0.0866	CbGeAlD
Spironolactone—AR—penis—skin cancer	0.0112	0.0823	CbGeAlD
Spironolactone—Amenorrhoea—Vismodegib—skin cancer	0.00946	0.0365	CcSEcCtD
Spironolactone—Rash erythematous—Imiquimod—skin cancer	0.00572	0.022	CcSEcCtD
Spironolactone—Vasculitis—Vemurafenib—skin cancer	0.00526	0.0203	CcSEcCtD
Spironolactone—Drug fever—Docetaxel—skin cancer	0.00523	0.0202	CcSEcCtD
Spironolactone—PGR—blood vessel—skin cancer	0.00505	0.0373	CbGeAlD
Spironolactone—Breast cancer—Docetaxel—skin cancer	0.00479	0.0184	CcSEcCtD
Spironolactone—Ulcer—Imiquimod—skin cancer	0.00463	0.0178	CcSEcCtD
Spironolactone—Gastrointestinal symptom NOS—Fluorouracil—skin cancer	0.00411	0.0159	CcSEcCtD
Spironolactone—SHBG—neck—skin cancer	0.00401	0.0296	CbGeAlD
Spironolactone—NR3C2—nipple—skin cancer	0.00393	0.029	CbGeAlD
Spironolactone—NR3C1—nerve—skin cancer	0.00371	0.0274	CbGeAlD
Spironolactone—Alopecia—Vismodegib—skin cancer	0.00369	0.0142	CcSEcCtD
Spironolactone—PGR—nipple—skin cancer	0.00365	0.0269	CbGeAlD
Spironolactone—Muscle spasms—Vismodegib—skin cancer	0.00349	0.0135	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00336	0.0129	CcSEcCtD
Spironolactone—Ulcer—Bleomycin—skin cancer	0.00329	0.0127	CcSEcCtD
Spironolactone—Lethargy—Imiquimod—skin cancer	0.00325	0.0125	CcSEcCtD
Spironolactone—Eosinophilia—Vemurafenib—skin cancer	0.00319	0.0123	CcSEcCtD
Spironolactone—Menstruation irregular—Docetaxel—skin cancer	0.00315	0.0122	CcSEcCtD
Spironolactone—Ulcer—Dactinomycin—skin cancer	0.00307	0.0118	CcSEcCtD
Spironolactone—Breast pain—Temozolomide—skin cancer	0.00301	0.0116	CcSEcCtD
Spironolactone—Amenorrhoea—Temozolomide—skin cancer	0.00299	0.0115	CcSEcCtD
Spironolactone—AR—nipple—skin cancer	0.00291	0.0215	CbGeAlD
Spironolactone—SHBG—connective tissue—skin cancer	0.00287	0.0212	CbGeAlD
Spironolactone—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00285	0.011	CcSEcCtD
Spironolactone—NR3C2—connective tissue—skin cancer	0.00279	0.0206	CbGeAlD
Spironolactone—CYP11B2—lymph node—skin cancer	0.0026	0.0192	CbGeAlD
Spironolactone—PGR—connective tissue—skin cancer	0.00259	0.0191	CbGeAlD
Spironolactone—Gastrointestinal disorder—Vismodegib—skin cancer	0.00256	0.00987	CcSEcCtD
Spironolactone—Ulcer—Fluorouracil—skin cancer	0.00256	0.00985	CcSEcCtD
Spironolactone—Erectile dysfunction—Imiquimod—skin cancer	0.00253	0.00975	CcSEcCtD
Spironolactone—PGR—epithelium—skin cancer	0.00246	0.0181	CbGeAlD
Spironolactone—Erythema multiforme—Vemurafenib—skin cancer	0.00244	0.0094	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00243	0.00936	CcSEcCtD
Spironolactone—NR3C2—mammalian vulva—skin cancer	0.00229	0.0169	CbGeAlD
Spironolactone—NR3C2—Preimplantation Embryo—PADI6—skin cancer	0.00228	0.224	CbGpPWpGaD
Spironolactone—Rash erythematous—Docetaxel—skin cancer	0.00228	0.00878	CcSEcCtD
Spironolactone—Alopecia—Vemurafenib—skin cancer	0.00228	0.00878	CcSEcCtD
Spironolactone—Lethargy—Dactinomycin—skin cancer	0.00215	0.00828	CcSEcCtD
Spironolactone—NR3C1—nipple—skin cancer	0.00211	0.0155	CbGeAlD
Spironolactone—Pruritus—Vismodegib—skin cancer	0.0021	0.00809	CcSEcCtD
Spironolactone—NR3C1—neck—skin cancer	0.00208	0.0154	CbGeAlD
Spironolactone—Erythema multiforme—Imiquimod—skin cancer	0.00208	0.00801	CcSEcCtD
Spironolactone—AR—connective tissue—skin cancer	0.00206	0.0152	CbGeAlD
Spironolactone—Diarrhoea—Vismodegib—skin cancer	0.00203	0.00782	CcSEcCtD
Spironolactone—SHBG—female reproductive system—skin cancer	0.00203	0.015	CbGeAlD
Spironolactone—Amenorrhoea—Docetaxel—skin cancer	0.00199	0.00766	CcSEcCtD
Spironolactone—NR3C2—female reproductive system—skin cancer	0.00196	0.0145	CbGeAlD
Spironolactone—AR—epithelium—skin cancer	0.00196	0.0145	CbGeAlD
Spironolactone—Alopecia—Imiquimod—skin cancer	0.00194	0.00749	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.0019	0.00731	CcSEcCtD
Spironolactone—PGR—lymphoid tissue—skin cancer	0.00189	0.014	CbGeAlD
Spironolactone—Vomiting—Vismodegib—skin cancer	0.00189	0.00727	CcSEcCtD
Spironolactone—Rash—Vismodegib—skin cancer	0.00187	0.00721	CcSEcCtD
Spironolactone—Dermatitis—Vismodegib—skin cancer	0.00187	0.0072	CcSEcCtD
Spironolactone—AR—skin of body—skin cancer	0.00186	0.0137	CbGeAlD
Spironolactone—Anaphylactic shock—Vemurafenib—skin cancer	0.00183	0.00706	CcSEcCtD
Spironolactone—PGR—female reproductive system—skin cancer	0.00183	0.0135	CbGeAlD
Spironolactone—Ataxia—Temozolomide—skin cancer	0.00179	0.0069	CcSEcCtD
Spironolactone—Lethargy—Fluorouracil—skin cancer	0.00179	0.0069	CcSEcCtD
Spironolactone—Ill-defined disorder—Imiquimod—skin cancer	0.00178	0.00685	CcSEcCtD
Spironolactone—Nausea—Vismodegib—skin cancer	0.00176	0.00679	CcSEcCtD
Spironolactone—Malaise—Imiquimod—skin cancer	0.00173	0.00665	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00172	0.00661	CcSEcCtD
Spironolactone—AR—mammalian vulva—skin cancer	0.0017	0.0125	CbGeAlD
Spironolactone—Ataxia—Fluorouracil—skin cancer	0.00165	0.00636	CcSEcCtD
Spironolactone—NR3C2—head—skin cancer	0.00164	0.0121	CbGeAlD
Spironolactone—Discomfort—Imiquimod—skin cancer	0.00161	0.00621	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00161	0.0062	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00158	0.0061	CcSEcCtD
Spironolactone—ABCC2—female reproductive system—skin cancer	0.00157	0.0116	CbGeAlD
Spironolactone—ABCB1—blood vessel—skin cancer	0.00156	0.0115	CbGeAlD
Spironolactone—PGR—head—skin cancer	0.00153	0.0113	CbGeAlD
Spironolactone—Erectile dysfunction—Temozolomide—skin cancer	0.00152	0.00585	CcSEcCtD
Spironolactone—Agranulocytosis—Dactinomycin—skin cancer	0.00152	0.00584	CcSEcCtD
Spironolactone—AR—lymphoid tissue—skin cancer	0.00151	0.0111	CbGeAlD
Spironolactone—Eosinophilia—Fluorouracil—skin cancer	0.0015	0.00579	CcSEcCtD
Spironolactone—NR3C1—connective tissue—skin cancer	0.00149	0.011	CbGeAlD
Spironolactone—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00146	0.00561	CcSEcCtD
Spironolactone—AR—female reproductive system—skin cancer	0.00145	0.0107	CbGeAlD
Spironolactone—Body temperature increased—Vemurafenib—skin cancer	0.00145	0.00558	CcSEcCtD
Spironolactone—NR3C1—epithelium—skin cancer	0.00142	0.0105	CbGeAlD
Spironolactone—SLCO1A2—head—skin cancer	0.00141	0.0104	CbGeAlD
Spironolactone—Somnolence—Imiquimod—skin cancer	0.00139	0.00535	CcSEcCtD
Spironolactone—Alopecia—Bleomycin—skin cancer	0.00138	0.00532	CcSEcCtD
Spironolactone—Erythema multiforme—Dactinomycin—skin cancer	0.00138	0.00531	CcSEcCtD
Spironolactone—Hypersensitivity—Vemurafenib—skin cancer	0.00135	0.0052	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Imiquimod—skin cancer	0.00135	0.0052	CcSEcCtD
Spironolactone—NR3C1—skin of body—skin cancer	0.00135	0.00995	CbGeAlD
Spironolactone—Pruritus—Vemurafenib—skin cancer	0.0013	0.005	CcSEcCtD
Spironolactone—Lethargy—Docetaxel—skin cancer	0.00129	0.00498	CcSEcCtD
Spironolactone—Alopecia—Dactinomycin—skin cancer	0.00129	0.00496	CcSEcCtD
Spironolactone—Feeling abnormal—Imiquimod—skin cancer	0.00129	0.00496	CcSEcCtD
Spironolactone—Agranulocytosis—Fluorouracil—skin cancer	0.00126	0.00487	CcSEcCtD
Spironolactone—Ill-defined disorder—Bleomycin—skin cancer	0.00126	0.00486	CcSEcCtD
Spironolactone—Diarrhoea—Vemurafenib—skin cancer	0.00125	0.00483	CcSEcCtD
Spironolactone—Erythema multiforme—Temozolomide—skin cancer	0.00125	0.0048	CcSEcCtD
Spironolactone—Urticaria—Imiquimod—skin cancer	0.00124	0.00478	CcSEcCtD
Spironolactone—Body temperature increased—Imiquimod—skin cancer	0.00124	0.00476	CcSEcCtD
Spironolactone—NR3C1—mammalian vulva—skin cancer	0.00123	0.00908	CbGeAlD
Spironolactone—Malaise—Bleomycin—skin cancer	0.00123	0.00473	CcSEcCtD
Spironolactone—Leukopenia—Bleomycin—skin cancer	0.00122	0.00469	CcSEcCtD
Spironolactone—AR—head—skin cancer	0.00122	0.00897	CbGeAlD
Spironolactone—Dizziness—Vemurafenib—skin cancer	0.00121	0.00467	CcSEcCtD
Spironolactone—Ataxia—Docetaxel—skin cancer	0.00119	0.00459	CcSEcCtD
Spironolactone—Ill-defined disorder—Dactinomycin—skin cancer	0.00118	0.00454	CcSEcCtD
Spironolactone—CYP2C8—female reproductive system—skin cancer	0.00118	0.00868	CbGeAlD
Spironolactone—Vomiting—Vemurafenib—skin cancer	0.00117	0.00449	CcSEcCtD
Spironolactone—Alopecia—Temozolomide—skin cancer	0.00117	0.00449	CcSEcCtD
Spironolactone—Rash—Vemurafenib—skin cancer	0.00116	0.00445	CcSEcCtD
Spironolactone—Dermatitis—Vemurafenib—skin cancer	0.00115	0.00445	CcSEcCtD
Spironolactone—Hypersensitivity—Imiquimod—skin cancer	0.00115	0.00444	CcSEcCtD
Spironolactone—NR3C2—lymph node—skin cancer	0.00115	0.00848	CbGeAlD
Spironolactone—Headache—Vemurafenib—skin cancer	0.00115	0.00442	CcSEcCtD
Spironolactone—Discomfort—Bleomycin—skin cancer	0.00114	0.00441	CcSEcCtD
Spironolactone—Malaise—Dactinomycin—skin cancer	0.00114	0.00441	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00114	0.0044	CcSEcCtD
Spironolactone—Cramp muscle—Docetaxel—skin cancer	0.00114	0.0044	CcSEcCtD
Spironolactone—Leukopenia—Dactinomycin—skin cancer	0.00114	0.00438	CcSEcCtD
Spironolactone—Confusional state—Bleomycin—skin cancer	0.00112	0.00431	CcSEcCtD
Spironolactone—Anaphylactic shock—Bleomycin—skin cancer	0.00111	0.00428	CcSEcCtD
Spironolactone—Pruritus—Imiquimod—skin cancer	0.00111	0.00426	CcSEcCtD
Spironolactone—NR3C1—lymphoid tissue—skin cancer	0.00109	0.00806	CbGeAlD
Spironolactone—Nausea—Vemurafenib—skin cancer	0.00109	0.00419	CcSEcCtD
Spironolactone—Thrombocytopenia—Bleomycin—skin cancer	0.00109	0.00419	CcSEcCtD
Spironolactone—Alopecia—Fluorouracil—skin cancer	0.00107	0.00414	CcSEcCtD
Spironolactone—Diarrhoea—Imiquimod—skin cancer	0.00107	0.00412	CcSEcCtD
Spironolactone—PGR—lymph node—skin cancer	0.00107	0.00788	CbGeAlD
Spironolactone—Discomfort—Dactinomycin—skin cancer	0.00107	0.00411	CcSEcCtD
Spironolactone—Ill-defined disorder—Temozolomide—skin cancer	0.00106	0.0041	CcSEcCtD
Spironolactone—NR3C1—female reproductive system—skin cancer	0.00105	0.00777	CbGeAlD
Spironolactone—Malaise—Temozolomide—skin cancer	0.00103	0.00399	CcSEcCtD
Spironolactone—Dizziness—Imiquimod—skin cancer	0.00103	0.00398	CcSEcCtD
Spironolactone—Leukopenia—Temozolomide—skin cancer	0.00103	0.00396	CcSEcCtD
Spironolactone—Thrombocytopenia—Dactinomycin—skin cancer	0.00101	0.00391	CcSEcCtD
Spironolactone—Vomiting—Imiquimod—skin cancer	0.000994	0.00383	CcSEcCtD
Spironolactone—Rash—Imiquimod—skin cancer	0.000986	0.0038	CcSEcCtD
Spironolactone—Dermatitis—Imiquimod—skin cancer	0.000985	0.00379	CcSEcCtD
Spironolactone—Headache—Imiquimod—skin cancer	0.000979	0.00377	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000968	0.00373	CcSEcCtD
Spironolactone—Discomfort—Temozolomide—skin cancer	0.000965	0.00372	CcSEcCtD
Spironolactone—Renal failure—Docetaxel—skin cancer	0.00096	0.0037	CcSEcCtD
Spironolactone—Leukopenia—Fluorouracil—skin cancer	0.000947	0.00365	CcSEcCtD
Spironolactone—Confusional state—Temozolomide—skin cancer	0.000944	0.00364	CcSEcCtD
Spironolactone—Anaphylactic shock—Temozolomide—skin cancer	0.000937	0.00361	CcSEcCtD
Spironolactone—Nausea—Imiquimod—skin cancer	0.000928	0.00358	CcSEcCtD
Spironolactone—ABCC2—lymph node—skin cancer	0.000917	0.00677	CbGeAlD
Spironolactone—Thrombocytopenia—Temozolomide—skin cancer	0.000917	0.00353	CcSEcCtD
Spironolactone—Feeling abnormal—Bleomycin—skin cancer	0.000915	0.00353	CcSEcCtD
Spironolactone—Agranulocytosis—Docetaxel—skin cancer	0.000911	0.00351	CcSEcCtD
Spironolactone—Discomfort—Fluorouracil—skin cancer	0.000889	0.00343	CcSEcCtD
Spironolactone—Urticaria—Bleomycin—skin cancer	0.000882	0.0034	CcSEcCtD
Spironolactone—NR3C1—head—skin cancer	0.00088	0.0065	CbGeAlD
Spironolactone—Body temperature increased—Bleomycin—skin cancer	0.000878	0.00338	CcSEcCtD
Spironolactone—Confusional state—Fluorouracil—skin cancer	0.00087	0.00335	CcSEcCtD
Spironolactone—Anaphylactic shock—Fluorouracil—skin cancer	0.000863	0.00333	CcSEcCtD
Spironolactone—Feeling abnormal—Dactinomycin—skin cancer	0.000853	0.00329	CcSEcCtD
Spironolactone—AR—lymph node—skin cancer	0.000851	0.00628	CbGeAlD
Spironolactone—Thrombocytopenia—Fluorouracil—skin cancer	0.000845	0.00326	CcSEcCtD
Spironolactone—Somnolence—Temozolomide—skin cancer	0.000833	0.00321	CcSEcCtD
Spironolactone—Erythema multiforme—Docetaxel—skin cancer	0.000829	0.00319	CcSEcCtD
Spironolactone—Body temperature increased—Dactinomycin—skin cancer	0.000819	0.00315	CcSEcCtD
Spironolactone—Hypersensitivity—Bleomycin—skin cancer	0.000818	0.00315	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Temozolomide—skin cancer	0.000809	0.00312	CcSEcCtD
Spironolactone—Pruritus—Bleomycin—skin cancer	0.000786	0.00303	CcSEcCtD
Spironolactone—Alopecia—Docetaxel—skin cancer	0.000775	0.00299	CcSEcCtD
Spironolactone—Feeling abnormal—Temozolomide—skin cancer	0.000772	0.00297	CcSEcCtD
Spironolactone—Somnolence—Fluorouracil—skin cancer	0.000767	0.00296	CcSEcCtD
Spironolactone—Hypersensitivity—Dactinomycin—skin cancer	0.000763	0.00294	CcSEcCtD
Spironolactone—ABCB1—epithelium—skin cancer	0.000759	0.0056	CbGeAlD
Spironolactone—NR3C2—Preimplantation Embryo—NKX2-1—skin cancer	0.000752	0.0739	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000745	0.00287	CcSEcCtD
Spironolactone—Urticaria—Temozolomide—skin cancer	0.000744	0.00287	CcSEcCtD
Spironolactone—Body temperature increased—Temozolomide—skin cancer	0.00074	0.00285	CcSEcCtD
Spironolactone—Muscle spasms—Docetaxel—skin cancer	0.000734	0.00283	CcSEcCtD
Spironolactone—Feeling abnormal—Fluorouracil—skin cancer	0.000711	0.00274	CcSEcCtD
Spironolactone—Diarrhoea—Dactinomycin—skin cancer	0.000709	0.00273	CcSEcCtD
Spironolactone—Vomiting—Bleomycin—skin cancer	0.000706	0.00272	CcSEcCtD
Spironolactone—Rash—Bleomycin—skin cancer	0.0007	0.0027	CcSEcCtD
Spironolactone—Dermatitis—Bleomycin—skin cancer	0.000699	0.0027	CcSEcCtD
Spironolactone—Hypersensitivity—Temozolomide—skin cancer	0.00069	0.00266	CcSEcCtD
Spironolactone—Urticaria—Fluorouracil—skin cancer	0.000686	0.00264	CcSEcCtD
Spironolactone—Leukopenia—Docetaxel—skin cancer	0.000683	0.00263	CcSEcCtD
Spironolactone—Body temperature increased—Fluorouracil—skin cancer	0.000682	0.00263	CcSEcCtD
Spironolactone—Pruritus—Temozolomide—skin cancer	0.000663	0.00255	CcSEcCtD
Spironolactone—Nausea—Bleomycin—skin cancer	0.00066	0.00254	CcSEcCtD
Spironolactone—ABCB1—mammalian vulva—skin cancer	0.000659	0.00486	CbGeAlD
Spironolactone—Vomiting—Dactinomycin—skin cancer	0.000658	0.00254	CcSEcCtD
Spironolactone—Rash—Dactinomycin—skin cancer	0.000653	0.00252	CcSEcCtD
Spironolactone—Diarrhoea—Temozolomide—skin cancer	0.000641	0.00247	CcSEcCtD
Spironolactone—Hypersensitivity—Fluorouracil—skin cancer	0.000636	0.00245	CcSEcCtD
Spironolactone—Confusional state—Docetaxel—skin cancer	0.000628	0.00242	CcSEcCtD
Spironolactone—Anaphylactic shock—Docetaxel—skin cancer	0.000623	0.0024	CcSEcCtD
Spironolactone—Dizziness—Temozolomide—skin cancer	0.000619	0.00239	CcSEcCtD
Spironolactone—NR3C1—lymph node—skin cancer	0.000616	0.00455	CbGeAlD
Spironolactone—Nausea—Dactinomycin—skin cancer	0.000615	0.00237	CcSEcCtD
Spironolactone—Pruritus—Fluorouracil—skin cancer	0.000611	0.00235	CcSEcCtD
Spironolactone—Thrombocytopenia—Docetaxel—skin cancer	0.00061	0.00235	CcSEcCtD
Spironolactone—Vomiting—Temozolomide—skin cancer	0.000596	0.00229	CcSEcCtD
Spironolactone—Rash—Temozolomide—skin cancer	0.000591	0.00228	CcSEcCtD
Spironolactone—Diarrhoea—Fluorouracil—skin cancer	0.00059	0.00228	CcSEcCtD
Spironolactone—Dermatitis—Temozolomide—skin cancer	0.00059	0.00227	CcSEcCtD
Spironolactone—Headache—Temozolomide—skin cancer	0.000587	0.00226	CcSEcCtD
Spironolactone—ABCB1—lymphoid tissue—skin cancer	0.000585	0.00432	CbGeAlD
Spironolactone—Dizziness—Fluorouracil—skin cancer	0.000571	0.0022	CcSEcCtD
Spironolactone—ABCB1—female reproductive system—skin cancer	0.000564	0.00416	CbGeAlD
Spironolactone—Nausea—Temozolomide—skin cancer	0.000556	0.00214	CcSEcCtD
Spironolactone—Somnolence—Docetaxel—skin cancer	0.000554	0.00213	CcSEcCtD
Spironolactone—Vomiting—Fluorouracil—skin cancer	0.000549	0.00211	CcSEcCtD
Spironolactone—Rash—Fluorouracil—skin cancer	0.000544	0.0021	CcSEcCtD
Spironolactone—Dermatitis—Fluorouracil—skin cancer	0.000544	0.00209	CcSEcCtD
Spironolactone—Headache—Fluorouracil—skin cancer	0.000541	0.00208	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Docetaxel—skin cancer	0.000538	0.00207	CcSEcCtD
Spironolactone—Feeling abnormal—Docetaxel—skin cancer	0.000513	0.00198	CcSEcCtD
Spironolactone—Nausea—Fluorouracil—skin cancer	0.000513	0.00198	CcSEcCtD
Spironolactone—Body temperature increased—Docetaxel—skin cancer	0.000492	0.0019	CcSEcCtD
Spironolactone—ABCB1—head—skin cancer	0.000471	0.00348	CbGeAlD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—KRT17—skin cancer	0.000461	0.0453	CbGpPWpGaD
Spironolactone—Hypersensitivity—Docetaxel—skin cancer	0.000459	0.00177	CcSEcCtD
Spironolactone—Pruritus—Docetaxel—skin cancer	0.000441	0.0017	CcSEcCtD
Spironolactone—Diarrhoea—Docetaxel—skin cancer	0.000426	0.00164	CcSEcCtD
Spironolactone—Dizziness—Docetaxel—skin cancer	0.000412	0.00159	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—KRT14—skin cancer	0.000411	0.0404	CbGpPWpGaD
Spironolactone—PGR—Ovarian Infertility Genes—MLH1—skin cancer	0.000409	0.0401	CbGpPWpGaD
Spironolactone—Vomiting—Docetaxel—skin cancer	0.000396	0.00153	CcSEcCtD
Spironolactone—Rash—Docetaxel—skin cancer	0.000393	0.00151	CcSEcCtD
Spironolactone—Dermatitis—Docetaxel—skin cancer	0.000392	0.00151	CcSEcCtD
Spironolactone—Headache—Docetaxel—skin cancer	0.00039	0.0015	CcSEcCtD
Spironolactone—Nausea—Docetaxel—skin cancer	0.00037	0.00143	CcSEcCtD
Spironolactone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	0.00033	0.0325	CbGpPWpGaD
Spironolactone—ABCB1—lymph node—skin cancer	0.00033	0.00243	CbGeAlD
Spironolactone—AR—FOXA1 transcription factor network—SHH—skin cancer	0.000252	0.0247	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—KRT5—skin cancer	0.000242	0.0238	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—ASIP—skin cancer	0.000242	0.0238	CbGpPWpGaD
Spironolactone—NR3C1—Endoderm Differentiation—NKX2-1—skin cancer	0.000233	0.0229	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—KRT14—skin cancer	0.000225	0.0221	CbGpPWpGaD
Spironolactone—SHBG—Nongenotropic Androgen signaling—HRAS—skin cancer	0.000213	0.021	CbGpPWpGaD
Spironolactone—PGR—Ovarian Infertility Genes—CDK4—skin cancer	0.000208	0.0204	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—skin cancer	0.000174	0.0171	CbGpPWpGaD
Spironolactone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—skin cancer	0.000161	0.0158	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—XRCC3—skin cancer	0.000155	0.0152	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—PLIN2—skin cancer	0.000146	0.0144	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000135	0.0133	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO4—skin cancer	0.000126	0.0124	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000104	0.0103	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.0001	0.00983	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—FOXO4—skin cancer	9.99e-05	0.00981	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MSH2—skin cancer	9.98e-05	0.00981	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO4—skin cancer	9.55e-05	0.00939	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—BRAF—skin cancer	9.13e-05	0.00897	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	9e-05	0.00884	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—skin cancer	8.49e-05	0.00835	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	7.78e-05	0.00764	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—skin cancer	7.53e-05	0.0074	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	7.37e-05	0.00724	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CDKN2A—skin cancer	7.22e-05	0.00709	CbGpPWpGaD
Spironolactone—AR—Nongenotropic Androgen signaling—HRAS—skin cancer	6.6e-05	0.00649	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RHOU—skin cancer	6.31e-05	0.0062	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—IL6—skin cancer	6.31e-05	0.0062	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—skin cancer	5.81e-05	0.00571	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—skin cancer	5.71e-05	0.00561	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.64e-05	0.00554	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	5.09e-05	0.005	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CDKN2A—skin cancer	4.9e-05	0.00482	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PLIN2—skin cancer	4.65e-05	0.00457	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.63e-05	0.00455	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CDK4—skin cancer	4.57e-05	0.00449	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—BRAF—skin cancer	4.05e-05	0.00398	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	4.04e-05	0.00397	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PLIN2—skin cancer	4.01e-05	0.00394	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	3.79e-05	0.00372	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CSPG4—skin cancer	3.75e-05	0.00368	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	3.7e-05	0.00364	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—NRAS—skin cancer	3.32e-05	0.00326	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CSPG4—skin cancer	3.23e-05	0.00317	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	3.17e-05	0.00311	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTCH2—skin cancer	3.08e-05	0.00303	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	3e-05	0.00295	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—KRAS—skin cancer	2.86e-05	0.00281	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.77e-05	0.00272	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—skin cancer	2.73e-05	0.00268	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	2.71e-05	0.00266	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ENO2—skin cancer	2.55e-05	0.0025	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PLIN2—skin cancer	2.51e-05	0.00247	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL6—skin cancer	2.5e-05	0.00246	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—HRAS—skin cancer	2.43e-05	0.00239	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—skin cancer	2.41e-05	0.00236	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GLI2—skin cancer	2.33e-05	0.00229	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ERCC2—skin cancer	2.33e-05	0.00229	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—IL6—skin cancer	2.32e-05	0.00228	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MC1R—skin cancer	2.23e-05	0.00219	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL6—skin cancer	2.2e-05	0.00216	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ENO2—skin cancer	2.2e-05	0.00216	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GLI1—skin cancer	2.2e-05	0.00216	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—KRAS—skin cancer	2.19e-05	0.00215	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.18e-05	0.00214	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SUFU—skin cancer	2.08e-05	0.00204	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CSPG4—skin cancer	2.03e-05	0.00199	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.99e-05	0.00196	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—skin cancer	1.95e-05	0.00191	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.81e-05	0.00178	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL6—skin cancer	1.73e-05	0.0017	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.72e-05	0.00169	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.61e-05	0.00158	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SHH—skin cancer	1.59e-05	0.00156	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RASA1—skin cancer	1.58e-05	0.00155	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.54e-05	0.00152	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IL6—skin cancer	1.52e-05	0.0015	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTCH1—skin cancer	1.5e-05	0.00148	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SMO—skin cancer	1.5e-05	0.00148	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ERCC2—skin cancer	1.48e-05	0.00145	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTGER4—skin cancer	1.46e-05	0.00144	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ERCC2—skin cancer	1.42e-05	0.00139	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ENO2—skin cancer	1.38e-05	0.00135	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—skin cancer	1.32e-05	0.00129	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FOXO4—skin cancer	1.29e-05	0.00127	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ERCC2—skin cancer	1.28e-05	0.00125	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLIN2—skin cancer	1.23e-05	0.00121	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.1e-05	0.00108	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ERCC2—skin cancer	1.08e-05	0.00106	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.08e-05	0.00106	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLIN2—skin cancer	1.08e-05	0.00106	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CSPG4—skin cancer	9.95e-06	0.000978	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—skin cancer	8.87e-06	0.000872	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CSPG4—skin cancer	8.67e-06	0.000852	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—skin cancer	8.64e-06	0.000849	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ERCC2—skin cancer	8.19e-06	0.000805	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ERCC2—skin cancer	8e-06	0.000786	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—skin cancer	7.65e-06	0.000751	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	7.39e-06	0.000726	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BRAF—skin cancer	6.84e-06	0.000672	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO2—skin cancer	6.76e-06	0.000665	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	6.57e-06	0.000646	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO2—skin cancer	5.89e-06	0.000579	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.29e-06	0.00052	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—skin cancer	4.79e-06	0.000471	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—skin cancer	4.3e-06	0.000423	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ERCC2—skin cancer	3.93e-06	0.000386	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—skin cancer	3.7e-06	0.000364	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ERCC2—skin cancer	3.42e-06	0.000336	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—skin cancer	3.29e-06	0.000323	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—skin cancer	3.15e-06	0.000309	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—skin cancer	3.01e-06	0.000296	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—skin cancer	2.36e-06	0.000232	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—skin cancer	2.05e-06	0.000202	CbGpPWpGaD
